Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 29 | % | 20299217 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | > | 20 | % | 20299217 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | > | 50 | % | 20299217 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 15000 | nM | 20185316 |
NPT2 | Others | Unspecified | IC50 | > | 25000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | = | 3162.3 | nM | PubChem BioAssay data set | |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 6309.6 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 5623.4 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 29092.9 | nM | PubChem BioAssay data set | |
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 5623.4 | nM | PubChem BioAssay data set | |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 25118.9 | nM | PubChem BioAssay data set | |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 25929 | nM | PubChem BioAssay data set | |
NPT2865 | Individual Protein | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | IC50 | = | 12500 | nM | PubChem BioAssay data set |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 18348.9 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 3548.1 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 5221.3 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT905 | Individual Protein | Glucose-6-phosphate 1-dehydrogenase | Homo sapiens | IC50 | > | 80000 | nM | PubChem BioAssay data set |
NPT1083 | Cell Line | A-375 | Homo sapiens | AC50 | > | 35000 | nM | PubChem BioAssay data set |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 7943.3 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 8912.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 891.3 | nM | PubChem BioAssay data set | ||
NPT2865 | Individual Protein | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | IC50 | > | 80000 | nM | PubChem BioAssay data set |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 5623.4 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 37933 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT702 | Individual Protein | UDP-glucuronosyltransferase 1-6 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT703 | Individual Protein | UDP-glucuronosyltransferase 1-9 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 7943.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 21192.3 | nM | PubChem BioAssay data set | ||
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 6513.1 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 15848.9 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT666 | Individual Protein | Solute carrier family 22 member 6 | Rattus norvegicus | Ki | = | 32000 | nM | 10220563 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 8199.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 10691 | nM | PubChem BioAssay data set | |
NPT477 | Individual Protein | DNA dC->dU-editing enzyme APOBEC-3G | Homo sapiens | Potency | 3162.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | 6633 | nM | PubChem BioAssay data set | ||
NPT4253 | Individual Protein | Beta Lactamase | Pseudomonas aeruginosa | IC50 | 43545 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 3162.3 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 7943.3 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 6309.6 | nM | PubChem BioAssay data set | |
NPT1853 | Individual Protein | Putative uncharacterized protein | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 4109.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 580.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7176.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5173.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1032.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10137.4 | nM | PubChem BioAssay data set | ||
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 1000 | nM | PubChem BioAssay data set | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 2909.3 | nM | PubChem BioAssay data set | |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 83.15 | % | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 42.04 | % | 23571415 |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 11455.4 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 12744.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 33488.9 | nM | PubChem BioAssay data set | ||
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 12744.8 | nM | PubChem BioAssay data set | ||
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 29847 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 29847 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 3592 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 33488.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 3201.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10209.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11876 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 9099.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 11455.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26832.5 | nM | PubChem BioAssay data set | ||
NPT831 | Individual Protein | Serine/threonine-protein kinase PLK1 | Homo sapiens | Potency | 23778.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 5692.9 | nM | PubChem BioAssay data set | ||
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 125.9 | nM | PubChem BioAssay data set | |
NPT162 | Individual Protein | Heat shock protein beta-1 | Homo sapiens | Potency | 3348.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 5073.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 9850 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14299.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2818.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 20000 | nM | PubChem BioAssay data set | ||
NPT74 | Individual Protein | Proto-oncogene c-JUN | Homo sapiens | Potency | 9520.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | 39810.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 10000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 4918.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 239.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2660.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 33491.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 8826.44 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 1662.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3757.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 39810.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8485.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9439.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 3293.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11883.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 28183.8 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC204156 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.75 | Intermediate Similarity | NPC146370 |
0.7134 | Intermediate Similarity | NPC144691 |
0.709 | Intermediate Similarity | NPC76327 |
0.6951 | Remote Similarity | NPC199737 |
0.6909 | Remote Similarity | NPC292143 |
0.6909 | Remote Similarity | NPC139506 |
0.6805 | Remote Similarity | NPC126676 |
0.6805 | Remote Similarity | NPC469671 |
0.6767 | Remote Similarity | NPC70201 |
0.6761 | Remote Similarity | NPC150308 |
0.6747 | Remote Similarity | NPC289776 |
0.6747 | Remote Similarity | NPC191863 |
0.6747 | Remote Similarity | NPC133470 |
0.6706 | Remote Similarity | NPC474814 |
0.6706 | Remote Similarity | NPC112336 |
0.669 | Remote Similarity | NPC222982 |
0.6686 | Remote Similarity | NPC33507 |
0.6667 | Remote Similarity | NPC47986 |
0.6667 | Remote Similarity | NPC91615 |
0.6619 | Remote Similarity | NPC255721 |
0.6607 | Remote Similarity | NPC204867 |
0.6594 | Remote Similarity | NPC44836 |
0.6587 | Remote Similarity | NPC93653 |
0.6571 | Remote Similarity | NPC9336 |
0.6561 | Remote Similarity | NPC315051 |
0.6556 | Remote Similarity | NPC5630 |
0.6552 | Remote Similarity | NPC474081 |
0.655 | Remote Similarity | NPC471778 |
0.6543 | Remote Similarity | NPC300596 |
0.6543 | Remote Similarity | NPC237649 |
0.6536 | Remote Similarity | NPC257390 |
0.6527 | Remote Similarity | NPC471122 |
0.6519 | Remote Similarity | NPC92803 |
0.6512 | Remote Similarity | NPC471648 |
0.6503 | Remote Similarity | NPC198401 |
0.65 | Remote Similarity | NPC18890 |
0.65 | Remote Similarity | NPC323798 |
0.6494 | Remote Similarity | NPC475607 |
0.6486 | Remote Similarity | NPC268348 |
0.6477 | Remote Similarity | NPC39822 |
0.6471 | Remote Similarity | NPC120251 |
0.646 | Remote Similarity | NPC16188 |
0.6456 | Remote Similarity | NPC150712 |
0.6442 | Remote Similarity | NPC257142 |
0.6437 | Remote Similarity | NPC475594 |
0.6434 | Remote Similarity | NPC264782 |
0.6433 | Remote Similarity | NPC471652 |
0.642 | Remote Similarity | NPC475761 |
0.6415 | Remote Similarity | NPC314113 |
0.6384 | Remote Similarity | NPC166169 |
0.6374 | Remote Similarity | NPC471124 |
0.6369 | Remote Similarity | NPC122542 |
0.6369 | Remote Similarity | NPC302235 |
0.6369 | Remote Similarity | NPC469428 |
0.6359 | Remote Similarity | NPC470485 |
0.6353 | Remote Similarity | NPC476231 |
0.6352 | Remote Similarity | NPC242933 |
0.6346 | Remote Similarity | NPC184437 |
0.6343 | Remote Similarity | NPC470548 |
0.6335 | Remote Similarity | NPC308197 |
0.6331 | Remote Similarity | NPC301163 |
0.6331 | Remote Similarity | NPC103250 |
0.6329 | Remote Similarity | NPC316574 |
0.6328 | Remote Similarity | NPC474041 |
0.6328 | Remote Similarity | NPC474815 |
0.6325 | Remote Similarity | NPC284348 |
0.6316 | Remote Similarity | NPC250476 |
0.6313 | Remote Similarity | NPC471785 |
0.631 | Remote Similarity | NPC315257 |
0.6306 | Remote Similarity | NPC473360 |
0.6304 | Remote Similarity | NPC311660 |
0.6303 | Remote Similarity | NPC233702 |
0.6292 | Remote Similarity | NPC271792 |
0.6289 | Remote Similarity | NPC469828 |
0.6286 | Remote Similarity | NPC73280 |
0.6286 | Remote Similarity | NPC477185 |
0.6284 | Remote Similarity | NPC321869 |
0.628 | Remote Similarity | NPC254798 |
0.6279 | Remote Similarity | NPC471130 |
0.6277 | Remote Similarity | NPC326792 |
0.6273 | Remote Similarity | NPC470090 |
0.6271 | Remote Similarity | NPC477187 |
0.6266 | Remote Similarity | NPC109580 |
0.6265 | Remote Similarity | NPC202198 |
0.6264 | Remote Similarity | NPC21425 |
0.6264 | Remote Similarity | NPC469915 |
0.6259 | Remote Similarity | NPC256838 |
0.6258 | Remote Similarity | NPC231382 |
0.6258 | Remote Similarity | NPC314098 |
0.6257 | Remote Similarity | NPC88970 |
0.6257 | Remote Similarity | NPC472117 |
0.625 | Remote Similarity | NPC203628 |
0.625 | Remote Similarity | NPC470483 |
0.625 | Remote Similarity | NPC476989 |
0.6243 | Remote Similarity | NPC138830 |
0.6242 | Remote Similarity | NPC253476 |
0.6242 | Remote Similarity | NPC242000 |
0.6237 | Remote Similarity | NPC276517 |
0.6226 | Remote Similarity | NPC242159 |
0.6226 | Remote Similarity | NPC313694 |
0.6222 | Remote Similarity | NPC314659 |
0.6221 | Remote Similarity | NPC313757 |
0.6201 | Remote Similarity | NPC298320 |
0.6196 | Remote Similarity | NPC260601 |
0.6196 | Remote Similarity | NPC474059 |
0.6185 | Remote Similarity | NPC299582 |
0.6175 | Remote Similarity | NPC473815 |
0.6169 | Remote Similarity | NPC218323 |
0.6167 | Remote Similarity | NPC197335 |
0.6167 | Remote Similarity | NPC270301 |
0.6163 | Remote Similarity | NPC475983 |
0.6163 | Remote Similarity | NPC315498 |
0.6163 | Remote Similarity | NPC230942 |
0.6159 | Remote Similarity | NPC125852 |
0.6158 | Remote Similarity | NPC127178 |
0.6149 | Remote Similarity | NPC472115 |
0.6149 | Remote Similarity | NPC472243 |
0.6149 | Remote Similarity | NPC472114 |
0.6139 | Remote Similarity | NPC266425 |
0.6134 | Remote Similarity | NPC53344 |
0.6134 | Remote Similarity | NPC478075 |
0.6131 | Remote Similarity | NPC469928 |
0.6129 | Remote Similarity | NPC473004 |
0.6127 | Remote Similarity | NPC20322 |
0.6125 | Remote Similarity | NPC166667 |
0.6124 | Remote Similarity | NPC129624 |
0.6121 | Remote Similarity | NPC9373 |
0.6117 | Remote Similarity | NPC303214 |
0.6115 | Remote Similarity | NPC313466 |
0.6111 | Remote Similarity | NPC5167 |
0.6111 | Remote Similarity | NPC22082 |
0.6111 | Remote Similarity | NPC475685 |
0.6111 | Remote Similarity | NPC85613 |
0.6111 | Remote Similarity | NPC186284 |
0.6108 | Remote Similarity | NPC473569 |
0.6105 | Remote Similarity | NPC309531 |
0.6105 | Remote Similarity | NPC27904 |
0.6105 | Remote Similarity | NPC472102 |
0.6098 | Remote Similarity | NPC473804 |
0.6096 | Remote Similarity | NPC322735 |
0.6095 | Remote Similarity | NPC36168 |
0.6093 | Remote Similarity | NPC473050 |
0.6093 | Remote Similarity | NPC473051 |
0.6092 | Remote Similarity | NPC70172 |
0.6087 | Remote Similarity | NPC75496 |
0.6085 | Remote Similarity | NPC472542 |
0.6085 | Remote Similarity | NPC472541 |
0.6084 | Remote Similarity | NPC315829 |
0.6081 | Remote Similarity | NPC147957 |
0.6077 | Remote Similarity | NPC288305 |
0.6074 | Remote Similarity | NPC476462 |
0.6074 | Remote Similarity | NPC472241 |
0.6071 | Remote Similarity | NPC154602 |
0.6069 | Remote Similarity | NPC472101 |
0.6069 | Remote Similarity | NPC472120 |
0.6065 | Remote Similarity | NPC476950 |
0.6064 | Remote Similarity | NPC243626 |
0.6064 | Remote Similarity | NPC93390 |
0.6064 | Remote Similarity | NPC230313 |
0.6061 | Remote Similarity | NPC119569 |
0.6057 | Remote Similarity | NPC182131 |
0.6056 | Remote Similarity | NPC188677 |
0.6056 | Remote Similarity | NPC88363 |
0.6054 | Remote Similarity | NPC329190 |
0.6053 | Remote Similarity | NPC138615 |
0.6053 | Remote Similarity | NPC100863 |
0.6053 | Remote Similarity | NPC132874 |
0.6053 | Remote Similarity | NPC265642 |
0.6053 | Remote Similarity | NPC218733 |
0.6051 | Remote Similarity | NPC270918 |
0.6051 | Remote Similarity | NPC16249 |
0.6049 | Remote Similarity | NPC314252 |
0.6048 | Remote Similarity | NPC473491 |
0.6045 | Remote Similarity | NPC85482 |
0.6039 | Remote Similarity | NPC472244 |
0.6039 | Remote Similarity | NPC171372 |
0.6039 | Remote Similarity | NPC470343 |
0.6037 | Remote Similarity | NPC168750 |
0.6036 | Remote Similarity | NPC285381 |
0.6034 | Remote Similarity | NPC189116 |
0.6033 | Remote Similarity | NPC262725 |
0.6032 | Remote Similarity | NPC470787 |
0.6032 | Remote Similarity | NPC472540 |
0.6032 | Remote Similarity | NPC472539 |
0.6032 | Remote Similarity | NPC472193 |
0.6031 | Remote Similarity | NPC14339 |
0.603 | Remote Similarity | NPC74562 |
0.603 | Remote Similarity | NPC316181 |
0.603 | Remote Similarity | NPC151781 |
0.6028 | Remote Similarity | NPC8931 |
0.6028 | Remote Similarity | NPC120693 |
0.6028 | Remote Similarity | NPC261573 |
0.6026 | Remote Similarity | NPC150863 |
0.6026 | Remote Similarity | NPC17374 |
0.6026 | Remote Similarity | NPC209389 |
0.6025 | Remote Similarity | NPC126637 |
0.6023 | Remote Similarity | NPC29285 |
0.6023 | Remote Similarity | NPC477889 |
0.6022 | Remote Similarity | NPC70092 |
0.6022 | Remote Similarity | NPC283810 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC204156 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD3391 | Approved |
0.8077 | Intermediate Similarity | NPD3387 | Approved |
0.7786 | Intermediate Similarity | NPD3865 | Approved |
0.7671 | Intermediate Similarity | NPD6636 | Phase 3 |
0.7548 | Intermediate Similarity | NPD5639 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD3141 | Discontinued |
0.7444 | Intermediate Similarity | NPD9376 | Approved |
0.7436 | Intermediate Similarity | NPD3229 | Phase 2 |
0.7415 | Intermediate Similarity | NPD2791 | Discontinued |
0.7413 | Intermediate Similarity | NPD9723 | Approved |
0.709 | Intermediate Similarity | NPD9507 | Approved |
0.7083 | Intermediate Similarity | NPD1544 | Phase 1 |
0.7078 | Intermediate Similarity | NPD4430 | Phase 2 |
0.7039 | Intermediate Similarity | NPD822 | Approved |
0.703 | Intermediate Similarity | NPD5823 | Approved |
0.7012 | Intermediate Similarity | NPD6533 | Clinical (unspecified phase) |
0.695 | Remote Similarity | NPD313 | Approved |
0.6941 | Remote Similarity | NPD5334 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD7449 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD7324 | Discontinued |
0.6815 | Remote Similarity | NPD1196 | Approved |
0.6784 | Remote Similarity | NPD2361 | Approved |
0.6779 | Remote Similarity | NPD5442 | Approved |
0.677 | Remote Similarity | NPD3277 | Phase 3 |
0.6752 | Remote Similarity | NPD1195 | Approved |
0.6739 | Remote Similarity | NPD3416 | Discontinued |
0.6725 | Remote Similarity | NPD2359 | Approved |
0.6709 | Remote Similarity | NPD2241 | Approved |
0.6703 | Remote Similarity | NPD4423 | Clinical (unspecified phase) |
0.6687 | Remote Similarity | NPD1543 | Discontinued |
0.6686 | Remote Similarity | NPD6457 | Approved |
0.6667 | Remote Similarity | NPD1168 | Approved |
0.6667 | Remote Similarity | NPD1342 | Approved |
0.6647 | Remote Similarity | NPD3793 | Phase 3 |
0.6646 | Remote Similarity | NPD2820 | Phase 3 |
0.6629 | Remote Similarity | NPD5637 | Discontinued |
0.6627 | Remote Similarity | NPD5294 | Clinical (unspecified phase) |
0.6608 | Remote Similarity | NPD1913 | Phase 1 |
0.659 | Remote Similarity | NPD5603 | Clinical (unspecified phase) |
0.6588 | Remote Similarity | NPD7126 | Discontinued |
0.6584 | Remote Similarity | NPD2114 | Discontinued |
0.6582 | Remote Similarity | NPD5719 | Approved |
0.6582 | Remote Similarity | NPD2365 | Approved |
0.6571 | Remote Similarity | NPD5445 | Approved |
0.655 | Remote Similarity | NPD1839 | Phase 1 |
0.6543 | Remote Similarity | NPD4161 | Discontinued |
0.6525 | Remote Similarity | NPD308 | Approved |
0.6522 | Remote Similarity | NPD3278 | Clinical (unspecified phase) |
0.6522 | Remote Similarity | NPD6884 | Clinical (unspecified phase) |
0.6522 | Remote Similarity | NPD6161 | Approved |
0.6522 | Remote Similarity | NPD6162 | Approved |
0.6519 | Remote Similarity | NPD2327 | Clinical (unspecified phase) |
0.6467 | Remote Similarity | NPD6320 | Approved |
0.6453 | Remote Similarity | NPD1161 | Approved |
0.6453 | Remote Similarity | NPD5186 | Approved |
0.6453 | Remote Similarity | NPD5183 | Approved |
0.6436 | Remote Similarity | NPD7071 | Clinical (unspecified phase) |
0.6434 | Remote Similarity | NPD1175 | Approved |
0.6432 | Remote Similarity | NPD5515 | Phase 2 |
0.6424 | Remote Similarity | NPD1678 | Clinical (unspecified phase) |
0.6407 | Remote Similarity | NPD4201 | Clinical (unspecified phase) |
0.6407 | Remote Similarity | NPD2672 | Discontinued |
0.6407 | Remote Similarity | NPD2469 | Approved |
0.6407 | Remote Similarity | NPD2468 | Approved |
0.6405 | Remote Similarity | NPD1271 | Clinical (unspecified phase) |
0.64 | Remote Similarity | NPD6645 | Clinical (unspecified phase) |
0.6395 | Remote Similarity | NPD3984 | Clinical (unspecified phase) |
0.6395 | Remote Similarity | NPD3983 | Phase 3 |
0.6386 | Remote Similarity | NPD5086 | Approved |
0.637 | Remote Similarity | NPD2638 | Clinical (unspecified phase) |
0.6369 | Remote Similarity | NPD7735 | Clinical (unspecified phase) |
0.6364 | Remote Similarity | NPD1170 | Approved |
0.6354 | Remote Similarity | NPD4515 | Suspended |
0.6345 | Remote Similarity | NPD9342 | Approved |
0.6341 | Remote Similarity | NPD4888 | Discontinued |
0.6337 | Remote Similarity | NPD6767 | Clinical (unspecified phase) |
0.6335 | Remote Similarity | NPD1625 | Approved |
0.6335 | Remote Similarity | NPD2129 | Approved |
0.6331 | Remote Similarity | NPD4514 | Approved |
0.6331 | Remote Similarity | NPD6283 | Phase 2 |
0.6331 | Remote Similarity | NPD156 | Phase 3 |
0.6329 | Remote Similarity | NPD9279 | Approved |
0.6319 | Remote Similarity | NPD5179 | Approved |
0.6319 | Remote Similarity | NPD5180 | Approved |
0.6319 | Remote Similarity | NPD5181 | Approved |
0.6312 | Remote Similarity | NPD7752 | Approved |
0.6312 | Remote Similarity | NPD7753 | Approved |
0.629 | Remote Similarity | NPD7880 | Clinical (unspecified phase) |
0.6282 | Remote Similarity | NPD7086 | Phase 2 |
0.6277 | Remote Similarity | NPD479 | Approved |
0.6275 | Remote Similarity | NPD850 | Approved |
0.6275 | Remote Similarity | NPD849 | Approved |
0.6275 | Remote Similarity | NPD848 | Approved |
0.6273 | Remote Similarity | NPD1189 | Approved |
0.6272 | Remote Similarity | NPD3812 | Clinical (unspecified phase) |
0.6272 | Remote Similarity | NPD3784 | Discontinued |
0.6271 | Remote Similarity | NPD5600 | Discontinued |
0.6269 | Remote Similarity | NPD3853 | Clinical (unspecified phase) |
0.6259 | Remote Similarity | NPD254 | Approved |
0.625 | Remote Similarity | NPD7174 | Clinical (unspecified phase) |
0.6243 | Remote Similarity | NPD8167 | Discontinued |
0.6243 | Remote Similarity | NPD6344 | Clinical (unspecified phase) |
0.6243 | Remote Similarity | NPD6021 | Clinical (unspecified phase) |
0.6243 | Remote Similarity | NPD6163 | Clinical (unspecified phase) |
0.6242 | Remote Similarity | NPD5556 | Clinical (unspecified phase) |
0.6235 | Remote Similarity | NPD4464 | Clinical (unspecified phase) |
0.6235 | Remote Similarity | NPD6060 | Clinical (unspecified phase) |
0.623 | Remote Similarity | NPD6608 | Clinical (unspecified phase) |
0.6225 | Remote Similarity | NPD522 | Approved |
0.6213 | Remote Similarity | NPD2366 | Approved |
0.6211 | Remote Similarity | NPD3625 | Discontinued |
0.6211 | Remote Similarity | NPD7083 | Clinical (unspecified phase) |
0.6207 | Remote Similarity | NPD6379 | Discontinued |
0.6203 | Remote Similarity | NPD5548 | Clinical (unspecified phase) |
0.6203 | Remote Similarity | NPD5582 | Discontinued |
0.6201 | Remote Similarity | NPD6654 | Clinical (unspecified phase) |
0.6199 | Remote Similarity | NPD4311 | Approved |
0.6196 | Remote Similarity | NPD7617 | Discontinued |
0.6194 | Remote Similarity | NPD2919 | Clinical (unspecified phase) |
0.6194 | Remote Similarity | NPD2918 | Clinical (unspecified phase) |
0.6186 | Remote Similarity | NPD2916 | Discontinued |
0.6185 | Remote Similarity | NPD4796 | Discontinued |
0.6183 | Remote Similarity | NPD4539 | Phase 1 |
0.6183 | Remote Similarity | NPD5610 | Approved |
0.6178 | Remote Similarity | NPD1594 | Phase 3 |
0.6178 | Remote Similarity | NPD1595 | Approved |
0.6176 | Remote Similarity | NPD1861 | Discovery |
0.6173 | Remote Similarity | NPD4597 | Approved |
0.6173 | Remote Similarity | NPD4598 | Approved |
0.6169 | Remote Similarity | NPD5993 | Phase 1 |
0.6168 | Remote Similarity | NPD8330 | Clinical (unspecified phase) |
0.6163 | Remote Similarity | NPD1743 | Approved |
0.6163 | Remote Similarity | NPD19 | Approved |
0.6163 | Remote Similarity | NPD1742 | Approved |
0.6163 | Remote Similarity | NPD4871 | Phase 2 |
0.6162 | Remote Similarity | NPD5871 | Discontinued |
0.6159 | Remote Similarity | NPD4775 | Clinical (unspecified phase) |
0.6159 | Remote Similarity | NPD4178 | Approved |
0.6159 | Remote Similarity | NPD4176 | Approved |
0.6159 | Remote Similarity | NPD6017 | Discontinued |
0.6145 | Remote Similarity | NPD3239 | Clinical (unspecified phase) |
0.6141 | Remote Similarity | NPD8025 | Phase 2 |
0.6139 | Remote Similarity | NPD1393 | Approved |
0.6139 | Remote Similarity | NPD756 | Suspended |
0.6129 | Remote Similarity | NPD3479 | Discontinued |
0.6127 | Remote Similarity | NPD1054 | Approved |
0.6127 | Remote Similarity | NPD3453 | Discontinued |
0.6121 | Remote Similarity | NPD1305 | Clinical (unspecified phase) |
0.6118 | Remote Similarity | NPD4255 | Phase 1 |
0.6118 | Remote Similarity | NPD2789 | Approved |
0.6111 | Remote Similarity | NPD3434 | Clinical (unspecified phase) |
0.6111 | Remote Similarity | NPD6211 | Clinical (unspecified phase) |
0.6111 | Remote Similarity | NPD6293 | Clinical (unspecified phase) |
0.6108 | Remote Similarity | NPD6136 | Phase 2 |
0.6108 | Remote Similarity | NPD5928 | Phase 1 |
0.6105 | Remote Similarity | NPD5599 | Discontinued |
0.6102 | Remote Similarity | NPD6365 | Clinical (unspecified phase) |
0.6101 | Remote Similarity | NPD2470 | Clinical (unspecified phase) |
0.6098 | Remote Similarity | NPD6506 | Clinical (unspecified phase) |
0.6098 | Remote Similarity | NPD2387 | Approved |
0.6098 | Remote Similarity | NPD5819 | Phase 2 |
0.6098 | Remote Similarity | NPD4347 | Clinical (unspecified phase) |
0.6094 | Remote Similarity | NPD6795 | Clinical (unspecified phase) |
0.6089 | Remote Similarity | NPD3449 | Discontinued |
0.6087 | Remote Similarity | NPD1626 | Approved |
0.608 | Remote Similarity | NPD5847 | Phase 1 |
0.608 | Remote Similarity | NPD4562 | Clinical (unspecified phase) |
0.6076 | Remote Similarity | NPD6740 | Clinical (unspecified phase) |
0.6071 | Remote Similarity | NPD1230 | Approved |
0.6059 | Remote Similarity | NPD948 | Phase 3 |
0.6054 | Remote Similarity | NPD286 | Approved |
0.6054 | Remote Similarity | NPD5620 | Clinical (unspecified phase) |
0.6053 | Remote Similarity | NPD3151 | Clinical (unspecified phase) |
0.6051 | Remote Similarity | NPD4781 | Approved |
0.6051 | Remote Similarity | NPD3118 | Clinical (unspecified phase) |
0.6051 | Remote Similarity | NPD4497 | Clinical (unspecified phase) |
0.6051 | Remote Similarity | NPD1314 | Clinical (unspecified phase) |
0.6051 | Remote Similarity | NPD4783 | Approved |
0.6047 | Remote Similarity | NPD2842 | Clinical (unspecified phase) |
0.6045 | Remote Similarity | NPD4083 | Discontinued |
0.6045 | Remote Similarity | NPD3975 | Discontinued |
0.6043 | Remote Similarity | NPD5937 | Approved |
0.6037 | Remote Similarity | NPD5024 | Approved |
0.6034 | Remote Similarity | NPD6383 | Clinical (unspecified phase) |
0.6034 | Remote Similarity | NPD6384 | Phase 2 |
0.6031 | Remote Similarity | NPD6138 | Clinical (unspecified phase) |
0.6029 | Remote Similarity | NPD6209 | Approved |
0.6025 | Remote Similarity | NPD4077 | Clinical (unspecified phase) |
0.6023 | Remote Similarity | NPD4205 | Phase 3 |
0.6023 | Remote Similarity | NPD7105 | Phase 1 |
0.6023 | Remote Similarity | NPD2821 | Approved |
0.6023 | Remote Similarity | NPD1187 | Discontinued |
0.6022 | Remote Similarity | NPD4081 | Clinical (unspecified phase) |
0.6022 | Remote Similarity | NPD5896 | Clinical (unspecified phase) |
0.602 | Remote Similarity | NPD4154 | Approved |
0.6012 | Remote Similarity | NPD3556 | Approved |
0.6012 | Remote Similarity | NPD3558 | Approved |
0.6012 | Remote Similarity | NPD3560 | Approved |
0.6012 | Remote Similarity | NPD9509 | Clinical (unspecified phase) |
0.6012 | Remote Similarity | NPD3557 | Approved |
PubChem CID   | 4641 |
ChEMBL   | CHEMBL1228 |
ZINC   |
Molecular Weight:   | 324.15 |
ALogP:   | -2.1437 |
MLogP:   | 3 |
XLogP:   | 4.49 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 60.85 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 1 |
# Rings:   | 3 |
# Heavy Atoms:   | 24 |